glp 1 shortage fda Novo Nordisk's semaglutide officially concludes in the US, spelling major threat for weight loss drug compounders Taking Stock: What Ro's GLP-1

While Semaglutide GLP-1 injections are primarily prescribed to those with diabetes, your physician may also suggest it if you have a weight related disorder

The case highlighted a distinct presentation from previously documented semaglutide reactions

doi: 10.1001/jamanetworkopen.2025.0081

However, similar to other chronic diseases such as T2D, the focus in obesity management (including pharmacotherapy prescription) over time will need to be shifted to primary care and collaborative integrated care models to be developed between specialist obesity services and primary care striving to meet the needs of people living with obesity [115]